Aug 04, 2022 / 12:00PM GMT
Operator
Good morning, and welcome to the Karyopharm Therapeutics Q2 '22 Earnings Conference Call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Ms. Elhan Webb, Senior Vice President, Investor Relations. Please go ahead.
Elhan Webb - Karyopharm Therapeutics Inc. - SVP of IR
Thank you, operator, and thank you all for joining us on today's conference call to discuss the Karyopharm Second Quarter 2022 financial result and recent company progress.
Today, I'm joined by Mr. Richard Paulson, President and Chief Executive Officer; Ms. Sohanya Cheng, Chief Commercial Officer; Dr. Reshma Rangwala, Chief Medical Officer; and Mr. Mike Mason, Chief Financial Officer.
Earlier this morning, we issued a press release detailing Karyopharm's financial results for the second quarter 2022. This release along with a slide presentation that we will reference during today's call are available under the Events & Presentation section of our website at Karyopharm
(technical difficulty)
Q2 2022 Karyopharm Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot